Advertisement

Topics

Companies Related to "The Safety and Effectiveness of Interferon Alfa-2B Plus Didanosine in Patients With Kaposi's Sarcoma" [Most Relevant Company Matches] RSS

22:47 EST 20th February 2019 | BioPortfolio

Here are the most relevant search results for "The Safety and Effectiveness of Interferon Alfa-2B Plus Didanosine in Patients With Kaposi's Sarcoma" found in our extensive corporate database of over 50,000 company records.

Showing "Safety Effectiveness Interferon Alfa Plus Didanosine Patients With" Companies 1–25 of 5,200+

Extremely Relevant

Interferon Sciences Incorporated

Interferon Sciences Incorporated is a biopharmaceutical company engaged in the study, manufacture, and sale of pharmaceutical products based on its highly purified, multispecies, natural source alpha interferon ("NaturalAlpha Interferon"). Interferon Sciences' ALFERON N Injection(R) (Interferon Alfa-n3) product has been approved by the United States Food and Drug Administration ("FDA...


Relevant

Resolve Therapeutics, LLC

Resolve Therapeutics is a privately held biotechnology company based in Seattle that is dedicated to helping patients with lupus through the development of RSLV-125, its novel targeted biologic therapy. RSLV-125 represents a new approach to inhibiting the production of interferon-alpha at a proximal step in the inflammatory cascade. A multitude of evidence...

Amarillo Biosciences Incorporated

Amarillo Biosciences, Inc., (ABI), is a biopharmaceutical company developing low-dose oral and topical interferon alpha. We are directing our research at the treatment of Behcet's Disease, and oral warts in HIV+ patients and chronic cough in idiopathic pulmonary fibrosis. Low-dose oral interferon is Fundamentally Different from high dose injectable interferon. In this site, we will show the fun...


Alfa Scientific Designs, Inc.

Alfa Scientific Designs, Inc. is a leader in the development and manufacture of rapid, immunoassay, point-of-care tests. As a minority, woman-owned, small business, ALFA offers a broad range of services, including contract product development, technology transfer, OEM services, custom assembly, and packaging with private labeling. ALFA has more than 50 FDA...

Assisted Living Federation of America (ALFA)

The Assisted Living Federation of America (ALFA) is the largest national association exclusively dedicated to professionally managed assisted living communities and the seniors and families they serve. For more than 20 years, ALFA has worked to educate policymakers and consumers by advocating for choice, independence, dignity and quality of life for senior...

EPOGEN® (Epoetin alfa)

EPOGEN® (Epoetin alfa), one of the first biologic human therapeutics, is approved for the treatment of anemia in patients with chronic kidney disease who are on dialysis.

Alfa Laval

Alfa Laval is a leading global provider of specialized products and engineered solutions. Our equipment, systems and services are dedicated to helping customers to optimize the performance of their processes. Time and time again. We help our customers to heat, cool, separate and transport products such as oil, water, chemicals, beverages, foodstuffs, starch and pharmaceuticals. Our worldwide organ...

Assisted Living Federation of America

The Assisted Living Federation of America (ALFA) is the largest national association exclusively dedicated to professionally managed assisted living communities and the seniors and families they serve. For 20 years, ALFA has worked to educate policymakers and consumers by advocating for informed choice, quality care, and accessibility for all Americans. ALFA's member-driven programs promote busi...

Alfa Wassermann, Inc

Under one name or another, Alfa Wassermann, Inc. has provided high quality products and services to the health care community since 1960. Our parent company, the Alfa Wassermann Group, headquartered in Bologna, Italy, has held a leadership position in the Italian pharmaceutical industry since the 1940's. Alfa Wassermann Inc. presently provides reliable and fully integrated clinical chemistry syste...

Aranesp

Aranesp® (darbepoetin alfa) is indicated for the treatment of anemia associated with chronic renal failure (CRF), including patients on dialysis and patients not on dialysis, and for the treatment of anemia in patients with nonmyeloid malignancies where anemia is due to the effect of concomitantly administered chemotherapy.Important Product Safety InformationAranesp® is contraindicated in patien...

PBL Biomedical Laboratories

Our goal is to be your first source for interferons, interferon antibodies, interferon ELISA kits, and related products.anti-interferon antibodies

EMD Serono, Inc.

EMD Serono, Inc., an affiliate of Merck KGaA, Darmstadt, Germany, is a leader in the US biopharmaceutical arena, integrating cutting-edge science with unparalleled patient support systems to improve people's lives. The company has strong market positions in neurodegenerative diseases, with Rebif® (interferon beta-1a), as well as in endocrinology, with S...

EMD Serono

EMD Serono, Inc., an affiliate of Merck KGaA, Darmstadt, Germany, is a leader in the US biopharmaceutical arena, integrating cutting-edge science with unparalleled patient support systems to improve people's lives. The company has strong market positions in neurodegenerative diseases, with Rebif® (interferon beta-1a), as well as in endocrinology, with S...

Aranesp® (darbepoetin alfa)

Aranesp® (darbepoetin alfa) is approved for the treatment of anemia associated with chronic kidney disease and chemotherapy.

Biolex, Inc

Biolex Therapeutics applies its unique drug development capabilities and expertise to commercialize complex proteins and monoclonal antibodies that until now have been impossible or very expensive to develop through traditional means. The company is advancing a proprietary pipeline of product candidates including Locteron™, a next-generation controlled-release form of alfa interferon which enter...

Biolex, Inc.

Biolex Therapeutics applies its unique drug development capabilities and expertise to commercialize complex proteins and monoclonal antibodies that until now have been impossible or very expensive to develop through traditional means. The company is advancing a proprietary pipeline of product candidates including Locteron™, a next-generation controlled-release form of alfa interferon which enter...

Alexion Pharmaceuticals Inc.

Alexion is a global biopharmaceutical company focused on developing and delivering life-transforming therapies for patients with devastating and rare disorders. Alexion developed and commercializes Soliris® (eculizumab), the first and only approved complement inhibitor to treat patients with paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemo...

Biogen Incorporated

Biogen, Inc. is a biopharmaceutical company principally engaged in the business of developing, manufacturing and marketing drugs for human health care. The Company currently derives revenues from sales of its AVONEX(R) (Interferon beta-1a) for the treatment of relapsing forms of multiple sclerosis and from sales by its licensees of a number of products, including alpha interferon, hepatitis B vacc...

REGISTRAT®, Inc

REGISTRAT Mission Statement is To partner with our sponsors, the scientific community, healthcare providers and patients to conduct quality research, advance scientific knowledge, gain clinical insights, and optimize the effectiveness and safety of medical products.

PBL InterferonSource

PBL InterferonSource, a division of Pestka Biomedical Laboratories based in Piscataway, N.J., USA, is the world’s leading supplier of interferon products to the life science researcher. Founded in 1990 by Dr. Sidney Pestka, PBL is the company that scientists turn to for their interferon-related needs: products, services, information, and know-how. The...

InterMune Pharmaceuticals

InterMune, Inc., is a biopharmaceutical company focused on developing and commercializing innovative therapies in hepatology and pulmonology. We market Actimmune® (interferon gamma-1b), approved for the treatment of severe, malignant osteopetrosis and chronic granulomatous disease. We have a late-stage and preclinical development pipeline in the areas of pulmonology and hepatology. In pulmono...

Advanced Sterilization Products

Advanced Sterilization Products (ASP) division of Ethicon, Inc., is a leading developer of innovative instrument sterilization, high-level disinfection, and cleaning technologies. The company is dedicated to protecting patients, healthcare workers, and the environment with products that focus as much on safety as they do on efficacy and cost-effectiveness. Utilizing advanced instrument processing ...

Alfa Chemicals Ltd

Alfa Chemicals Ltd. is one of the leading distributors of speciality chemicals throughout the UK & Ireland. Since its formation in 1976, we have remained independent and stuck closely to our fundamental premise of working in partnership with our Principals & Customers.We are particularly strong in the following markets: Pharmaceutical, Personal Care, Nutraceutical, Plastics & Polyurethanes, Coatin...

Nuron Biotech, Inc.

Nuron Biotech is developing novel biologics and vaccines for the prevention and treatment of neurodegenerative and infectious diseases. Its team of industry veterans is committed to advancing products that meet unmet medical needs for patients around the globe. Nuron Biotech’s lead drug candidate, RELONSIV™ (interferon beta-1b), is a new chemical ...

Flamel Technologies SA and Digna Biotech SL

Flamel Technologies SA (NASDAQ: FLML) is a leading drug delivery company focused on the goal of developing safer, more efficacious formulations of drugs that address unmet medical needs. Its product development pipeline includes biological and chemical drugs formulated with the Medusa® and Micropump® proprietary platforms. Several Medusa-based produc...


More From BioPortfolio on "The Safety and Effectiveness of Interferon Alfa-2B Plus Didanosine in Patients With Kaposi's Sarcoma"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks